RMD Resmed Inc

Price (delayed)

$221.985

Market cap

$32.61B

P/E Ratio

40.14

Dividend/share

$1.72

EPS

$5.53

Enterprise value

$34.3B

ResMed is a San Diego, California-based medical equipment company. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea , chronic obstructive pulmonary disease , and other respiratory ...

Highlights
RMD's net income has soared by 55% YoY and by 2.9% QoQ
The EPS has soared by 54% YoY and by 2.8% from the previous quarter
Resmed's debt has surged by 132% YoY and by 108% QoQ

Key stats

What are the main financial stats of RMD
Market
Shares outstanding
146.91M
Market cap
$32.61B
Enterprise value
$34.3B
Valuations
Price to earnings (P/E)
40.14
Price to book (P/B)
8.7
Price to sales (P/S)
8.65
EV/EBIT
33.35
EV/EBITDA
28.24
EV/Sales
9.11
Earnings
Revenue
$3.76B
EBIT
$1.03B
EBITDA
$1.21B
Free cash flow
$236.73M
Per share
EPS
$5.53
Free cash flow per share
$1.61
Book value per share
$25.52
Revenue per share
$25.65
TBVPS
$22.64
Balance sheet
Total assets
$6.68B
Total liabilities
$2.94B
Debt
$1.94B
Equity
$3.74B
Working capital
$1.59B
Liquidity
Debt to equity
0.52
Current ratio
3.17
Quick ratio
1.26
Net debt/EBITDA
1.39
Margins
EBITDA margin
32.3%
Gross margin
56.7%
Net margin
21.5%
Operating margin
27.8%
Efficiency
Return on assets
14.8%
Return on equity
23.4%
Return on invested capital
32.8%
Return on capital employed
17.3%
Return on sales
27.3%
Dividend
Dividend yield
0.77%
DPS
$1.72
Payout ratio
31.1%

RMD stock price

How has the Resmed stock price performed over time
Intraday
-1.16%
1 week
-6.15%
1 month
6.66%
1 year
2.71%
YTD
6.66%
QTD
6.66%

Financial performance

How have Resmed's revenue and profit performed over time
Revenue
$3.76B
Gross profit
$2.13B
Operating income
$1.05B
Net income
$809.47M
Gross margin
56.7%
Net margin
21.5%
RMD's net income has soared by 55% YoY and by 2.9% QoQ
Resmed's net margin has increased by 41% YoY
The gross profit has grown by 10% YoY and by 3.7% from the previous quarter
The company's revenue rose by 9% YoY and by 3.8% QoQ

Growth

What is Resmed's growth rate over time

Valuation

What is Resmed stock price valuation
P/E
40.14
P/B
8.7
P/S
8.65
EV/EBIT
33.35
EV/EBITDA
28.24
EV/Sales
9.11
The EPS has soared by 54% YoY and by 2.8% from the previous quarter
The price to earnings (P/E) is 16% lower than the 5-year quarterly average of 48.2
RMD's equity is up by 19% year-on-year and by 9% since the previous quarter
RMD's P/B is 8% below its 5-year quarterly average of 9.6 and 6% below its last 4 quarters average of 9.4
The company's revenue rose by 9% YoY and by 3.8% QoQ
The P/S is 4.3% higher than the 5-year quarterly average of 8.4

Efficiency

How efficient is Resmed business performance
The ROA has increased by 33% YoY but it has decreased by 6% from the previous quarter
Resmed's ROE has increased by 32% YoY
The company's return on invested capital fell by 25% YoY and by 11% QoQ
The ROS has decreased by 3.5% YoY

Dividends

What is RMD's dividend history
DPS
$1.72
Dividend yield
0.77%
Payout ratio
31.1%
Recent dividends

Financial health

How did Resmed financials performed over time
The company's total assets is 127% higher than its total liabilities
RMD's total liabilities has surged by 85% year-on-year and by 68% since the previous quarter
The company's total assets rose by 41% YoY and by 29% QoQ
Resmed's debt is 48% lower than its equity
Resmed's debt has surged by 132% YoY and by 108% QoQ
Resmed's debt to equity has surged by 93% QoQ and by 93% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.